Lu W - Search Results

1

Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model.

Tantawy MN, Charles Manning H, Peterson TE, Colvin DC, Gore JC, Lu W, Chen Z, Chad Quarles C. Tantawy MN, et al. Among authors: lu w. Mol Imaging Biol. 2018 Apr;20(2):200-204. doi: 10.1007/s11307-017-1113-7. Mol Imaging Biol. 2018. PMID: 28822038 Free PMC article.

2

ARF represses androgen receptor transactivation in prostate cancer.

Lu W, Xie Y, Ma Y, Matusik RJ, Chen Z. Lu W, et al. Mol Endocrinol. 2013 Apr;27(4):635-48. doi: 10.1210/me.2012-1294. Epub 2013 Feb 28. Mol Endocrinol. 2013. PMID: 23449888 Free PMC article.

3

Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.

Li B, Lu W, Yang Q, Yu X, Matusik RJ, Chen Z. Li B, et al. Among authors: lu w. Prostate. 2014 Apr;74(4):421-32. doi: 10.1002/pros.22763. Epub 2013 Dec 17. Prostate. 2014. PMID: 24347472 Free PMC article.

4

Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis.

Xie Y, Liu S, Lu W, Yang Q, Williams KD, Binhazim AA, Carver BS, Matusik RJ, Chen Z. Xie Y, et al. Among authors: lu w. Mol Oncol. 2014 Oct;8(7):1355-64. doi: 10.1016/j.molonc.2014.05.006. Epub 2014 May 21. Mol Oncol. 2014. PMID: 24910389 Free PMC article.

5

Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer.

Xie Y, Lu W, Liu S, Yang Q, Carver BS, Li E, Wang Y, Fazli L, Gleave M, Chen Z. Xie Y, et al. Among authors: lu w. Mol Endocrinol. 2014 Oct;28(10):1629-39. doi: 10.1210/me.2014-1078. Epub 2014 Aug 6. Mol Endocrinol. 2014. PMID: 25099011 Free PMC article.

6

Regulation of Androgen Receptor by E3 Ubiquitin Ligases: for More or Less.

Li B, Lu W, Chen Z. Li B, et al. Among authors: lu w. Receptors Clin Investig. 2014;1(5):10.14800%2Frci.122. doi: 10.14800/rci.122. Receptors Clin Investig. 2014. PMID: 25152898 Free PMC article.

7

Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling.

Wanjala J, Taylor BS, Chapinski C, Hieronymus H, Wongvipat J, Chen Y, Nanjangud GJ, Schultz N, Xie Y, Liu S, Lu W, Yang Q, Sander C, Chen Z, Sawyers CL, Carver BS. Wanjala J, et al. Among authors: lu w. Mol Cancer Ther. 2015 Jan;14(1):278-88. doi: 10.1158/1535-7163.MCT-14-0542-T. Epub 2014 Nov 7. Mol Cancer Ther. 2015. PMID: 25381262 Free PMC article.

8

SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.

Lu W, Liu S, Li B, Xie Y, Adhiambo C, Yang Q, Ballard BR, Nakayama KI, Matusik RJ, Chen Z. Lu W, et al. Oncotarget. 2015 Jan 20;6(2):771-88. doi: 10.18632/oncotarget.2718. Oncotarget. 2015. PMID: 25596733 Free PMC article.

9

Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.

Chen Z, Lu W. Chen Z, et al. Among authors: lu w. Int J Mol Sci. 2015 Feb 27;16(3):4560-80. doi: 10.3390/ijms16034560. Int J Mol Sci. 2015. PMID: 25734985 Free PMC article. Review.

10

MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo.

Xie Y, Lu W, Liu S, Yang Q, Goodwin JS, Sathyanarayana SA, Pratap S, Chen Z. Xie Y, et al. Among authors: lu w. Oncotarget. 2016 Jul 26;7(30):47609-47619. doi: 10.18632/oncotarget.10251. Oncotarget. 2016. PMID: 27356744 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,771 results

Search Page

Filters